Jim Cramer's Stop Trading: GWPH

NEW YORK (TheStreet) -- Morgan Stanley initiated coverage on GW Pharma (GWPH) with a buy rating and a $103 price target.

"This stock will be up the most of any stock other than Allergan (AGN) today," TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, said on CNBC's "Cramer's Stop Trading" segment. 

"This is a cannabis stock" -- not a medical marijuana stock, he argued. He said GW Pharma is "a real company" that has other business segments, while also having operations in the medical marijuana field.  

"I am shocked at this" bold and timely analyst action, Cramer concluded, calling GW Pharma his favorite cannabis stock.


-- Written by Bret Kenwell in Petoskey, Mich.

At the time of publication, Cramer's Action Alerts PLUS had no position in companies mentioned.

More from Opinion

AAP Exclusive: Cramer Says The President is No Longer on the Side of the Bulls

AAP Exclusive: Cramer Says The President is No Longer on the Side of the Bulls

Why It Makes Perfect Sense for Netflix and Amazon to Buy Up Movie Theaters

Why It Makes Perfect Sense for Netflix and Amazon to Buy Up Movie Theaters

2 More Reasons to Sell All Your Stocks and Run Away

2 More Reasons to Sell All Your Stocks and Run Away

Sean Hannity's Link to Trump Lawyer Raises Questions: Doug Kass Insider

Sean Hannity's Link to Trump Lawyer Raises Questions: Doug Kass Insider

Netflix Blowout Earnings Remind Investors of One Thing: This Company Is a Beast

Netflix Blowout Earnings Remind Investors of One Thing: This Company Is a Beast